Galderma Group AG
GALD
Rangering i aksjer
#456
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Aksjekurs
$224.81
Sist synkronisert: 2026-10-22
Markedsverdi
$52.42B
Endring (1 dag)
6.31%
Endring (1 år)
27.96%
Land
CH
Handel Galderma Group AG (GALD)
Kategori
Healthcare
Utbyttehistorikk for Galderma Group AG (GALD)
Galderma Group AG (aksjesymbol: GALD) har gitt totalt 2 utbyttebetalinger.
Summen av alle utbytter (justert for aksjesplitt): $0.50
Utbytteavkastning (TTM): 0.0019
Summen av alle utbytter (justert for aksjesplitt): $0.50
Utbytteavkastning (TTM): 0.0019
Utbyttebetalinger for Galderma Group AG (GALD) fra 2025 til 2026
Årlige utbyttebetalinger
| År | Utbytte (justert for aksjesplitt) | Endre |
|---|---|---|
| 2026 (TTM) | $0.35 | 133.33% |
| 2025 | $0.15 | 0.00% |
Liste over alle utbyttebetalinger
| År | Utbytte | Endre |
|---|---|---|
| 2026 (TTM) | $0.35 | 133.33% |
| 2025 | $0.15 | 0.00% |
Utbyttebetalinger for lignende selskaper eller konkurrenter
| Selskap | Antall utbyttebetalinger | Land |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 26.00% |
CN
|
|
| 39.00% |
IN
|
